Key Details
Price
$30.88Last Dividend
$0.17TTM Dividend Yield
3.37%PE Ratio
154.40Annual ROE
36.98%Beta
0.37Events Calendar
Next earnings date:
Feb 13, 2025Recent quarterly earnings:
Nov 8, 2024Recent annual earnings:
Feb 8, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Nov 29, 2024Next split:
N/ARecent split:
Jul 1, 2015Analyst ratings
Recent major analysts updates
Market Data
Price
Market cap
Technical
Dividend
Events
Dividend per share
Dividend yield
Other
Profitability
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Liquidity
Leverage
Risk & Stability
Balance Sheet
Assets
Equity
Liabilities
Debt
Expenses
Cash Flow
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
Baxter International, a company that makes medical products, announced on Monday that its CEO, José Almeida, will retire right away after almost ten years in the role.
In the stock market, not every stock performs well. Some stocks end up struggling and are affected by the changing feelings of investors.
BAX has introduced five new injectable products in the United States, which enhances its pharmaceutical business in the country. This move helps to solidify BAX's presence in the U.S. market.
Investors should closely monitor Baxter International (BAX) stock due to recent changes in the options market.
On Thursday, Baxter International announced that it has restarted production on all dialysis solution manufacturing lines at its North Carolina plant, which had been affected by flooding from a hurricane.
Baxter International Inc., a leading global medical technology company, has announced a quarterly cash dividend of $0.17 per share of common stock. This dividend will be paid on January 2, 2025, to shareholders who are on record as of November 29, 2024. The annual dividend rate is set at $0.68 per share, reflecting the company's new quarterly rate ahead of the sale of its Kidney Care business.
Baxter has announced third-quarter results that are better than anticipated. However, the company's gross and operating margins have decreased.
Baxter International (BAX) reported quarterly earnings of $0.80 per share, which is higher than the Zacks Consensus Estimate of $0.78 per share. This is an increase compared to earnings of $0.68 per share from the same period last year.
On Friday, Baxter International lowered its yearly profit expectations because its intravenous solutions plant was affected by a hurricane, causing its stock to drop by 3.3% in early trading.
Baxter International Inc. (NYSE:BAX) will hold its Q3 2024 Earnings Conference Call on November 8, 2024, at 8:30 AM ET. The call will feature company leaders, including Clare Trachtman, Joe Almeida, and Joel Grade, along with participants from various financial institutions. Attendees will be in listen-only mode until the question-and-answer portion begins.
FAQ
- What is the ticker symbol for Baxter International?
- Does Baxter International pay dividends?
- What sector is Baxter International in?
- What industry is Baxter International in?
- What country is Baxter International based in?
- When did Baxter International go public?
- Is Baxter International in the S&P 500?
- Is Baxter International in the NASDAQ 100?
- Is Baxter International in the Dow Jones?
- When was Baxter International's last earnings report?
- When does Baxter International report earnings?
- Should I buy Baxter International stock now?